Igfbp5 Rat (+)-catechin multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of IGFBP5 mRNA CTD PMID:24763279 Igfbp5 Rat (1->4)-beta-D-glucan multiple interactions ISO Igfbp5 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of IGFBP5 mRNA CTD PMID:36331819 Igfbp5 Rat (R,R,R)-alpha-tocopherol multiple interactions EXP 6480464 [alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium more ... CTD PMID:23859036 Igfbp5 Rat 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane decreases expression ISO Igfbp5 (Mus musculus) 6480464 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane results in decreased expression of IGFBP5 mRNA CTD PMID:11509743 Igfbp5 Rat 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane affects expression EXP 6480464 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the expression of IGFBP5 mRNA CTD PMID:19414516 Igfbp5 Rat 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane multiple interactions EXP 6480464 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [Cyclic AMP affects the expression of IGFBP5 mRNA]; 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the more ... CTD PMID:19414516 Igfbp5 Rat 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane multiple interactions ISO Igfbp5 (Mus musculus) 6480464 [Estradiol co-treated with 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane] results in decreased expression of IGFBP5 mRNA CTD PMID:11509743 Igfbp5 Rat 1,10-phenanthroline decreases degradation EXP 6480464 1,10-phenanthroline results in decreased degradation of IGFBP5 protein CTD PMID:8894652 Igfbp5 Rat 1,2-dichloroethane increases expression ISO Igfbp5 (Mus musculus) 6480464 ethylene dichloride results in increased expression of IGFBP5 mRNA CTD PMID:28960355 Igfbp5 Rat 1,2-dimethylhydrazine increases expression ISO Igfbp5 (Mus musculus) 6480464 1,2-Dimethylhydrazine results in increased expression of IGFBP5 mRNA CTD PMID:22206623 Igfbp5 Rat 1,2-dimethylhydrazine multiple interactions ISO Igfbp5 (Mus musculus) 6480464 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of IGFBP5 mRNA CTD PMID:22206623 Igfbp5 Rat 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of IGFBP5 mRNA CTD PMID:30723492 Igfbp5 Rat 14-Deoxy-11,12-didehydroandrographolide decreases expression ISO IGFBP5 (Homo sapiens) 6480464 14-deoxy-11,12-didehydroandrographolide results in decreased expression of IGFBP5 mRNA CTD PMID:22101062 Igfbp5 Rat 17alpha-ethynylestradiol increases expression ISO Igfbp5 (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of IGFBP5 mRNA CTD PMID:17942748 Igfbp5 Rat 17alpha-ethynylestradiol decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Ethinyl Estradiol results in decreased expression of IGFBP5 mRNA CTD PMID:18936297 Igfbp5 Rat 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of IGFBP5 mRNA CTD PMID:17557909 Igfbp5 Rat 17alpha-ethynylestradiol multiple interactions ISO Igfbp5 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of IGFBP5 mRNA CTD PMID:17942748 Igfbp5 Rat 17beta-estradiol multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of IGFBP5 mRNA; [Estradiol co-treated with Tetrachlorodibenzodioxin] more ... CTD PMID:19619570|PMID:20660070|PMID:31646340 Igfbp5 Rat 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of IGFBP5 mRNA CTD PMID:32145629 Igfbp5 Rat 17beta-estradiol decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Estradiol results in decreased expression of IGFBP5 mRNA CTD PMID:15159206|PMID:21185374|PMID:31646340 Igfbp5 Rat 17beta-estradiol affects expression ISO IGFBP5 (Homo sapiens) 6480464 Estradiol affects the expression of IGFBP5 mRNA CTD PMID:14699072|PMID:21826169 Igfbp5 Rat 17beta-estradiol decreases expression ISO Igfbp5 (Mus musculus) 6480464 Estradiol results in decreased expression of IGFBP5 mRNA CTD PMID:11509743|PMID:39298647 Igfbp5 Rat 17beta-estradiol multiple interactions ISO Igfbp5 (Mus musculus) 6480464 [Estradiol co-treated with 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane] results in decreased expression of IGFBP5 mRNA; [Estradiol co-treated with Methoxychlor more ... CTD PMID:11509743 Igfbp5 Rat 17beta-estradiol increases expression ISO IGFBP5 (Homo sapiens) 6480464 Estradiol results in increased expression of IGFBP5 mRNA CTD PMID:17555868|PMID:19619570 Igfbp5 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of IGFBP5 mRNA CTD PMID:19619570 Igfbp5 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of IGFBP5 mRNA CTD PMID:33387578 Igfbp5 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO IGFBP5 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin affects the expression of IGFBP5 mRNA CTD PMID:36370075 Igfbp5 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of IGFBP5 mRNA CTD PMID:34747641 Igfbp5 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Igfbp5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of IGFBP5 mRNA CTD PMID:26139165 Igfbp5 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Igfbp5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of IGFBP5 mRNA CTD PMID:17555868|PMID:21570461 Igfbp5 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO IGFBP5 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of IGFBP5 mRNA CTD PMID:17555868|PMID:19619570 Igfbp5 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Igfbp5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of IGFBP5 mRNA CTD PMID:16054899 Igfbp5 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Igfbp5 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine more ... CTD PMID:16054899|PMID:17942748 Igfbp5 Rat 2,4,6-trinitrobenzenesulfonic acid multiple interactions ISO Igfbp5 (Mus musculus) 6480464 Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IGFBP5 mRNA] CTD PMID:18200517 Igfbp5 Rat 2,4,6-trinitrobenzenesulfonic acid increases expression ISO Igfbp5 (Mus musculus) 6480464 Trinitrobenzenesulfonic Acid results in increased expression of IGFBP5 mRNA CTD PMID:17982090|PMID:18200517 Igfbp5 Rat 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression ISO Igfbp5 (Mus musculus) 6480464 2,2',4,4',5-brominated diphenyl ether affects the expression of IGFBP5 mRNA CTD PMID:38648751 Igfbp5 Rat 2-amino-2-deoxy-D-glucopyranose multiple interactions EXP 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of IGFBP5 mRNA] CTD PMID:17109745 Igfbp5 Rat 2-amino-2-deoxy-D-glucopyranose increases expression EXP 6480464 Glucosamine results in increased expression of IGFBP5 mRNA CTD PMID:17109745 Igfbp5 Rat 2-methylcholine affects expression ISO IGFBP5 (Homo sapiens) 6480464 beta-methylcholine affects the expression of IGFBP5 mRNA CTD PMID:21179406 Igfbp5 Rat 3',5'-cyclic AMP multiple interactions EXP 6480464 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [Cyclic AMP affects the expression of IGFBP5 mRNA] CTD PMID:19414516 Igfbp5 Rat 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of IGFBP5 mRNA CTD PMID:23196670 Igfbp5 Rat 3,3',5,5'-tetrabromobisphenol A decreases expression ISO Igfbp5 (Mus musculus) 6480464 tetrabromobisphenol A results in decreased expression of IGFBP5 mRNA CTD PMID:25172293 Igfbp5 Rat 3,3',5,5'-tetrabromobisphenol A decreases expression ISO IGFBP5 (Homo sapiens) 6480464 tetrabromobisphenol A results in decreased expression of IGFBP5 mRNA CTD PMID:33476716 Igfbp5 Rat 3,4-methylenedioxymethamphetamine increases expression ISO Igfbp5 (Mus musculus) 6480464 N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of IGFBP5 mRNA CTD PMID:20188158 Igfbp5 Rat 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO Igfbp5 (Mus musculus) 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression more ... CTD PMID:16054899 Igfbp5 Rat 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression more ... CTD PMID:28628672 Igfbp5 Rat 4,4'-sulfonyldiphenol decreases expression ISO IGFBP5 (Homo sapiens) 6480464 bisphenol S results in decreased expression of IGFBP5 mRNA CTD PMID:33476716 Igfbp5 Rat 4,4'-sulfonyldiphenol decreases expression ISO Igfbp5 (Mus musculus) 6480464 bisphenol S results in decreased expression of IGFBP5 mRNA CTD PMID:39298647 Igfbp5 Rat 4,4'-sulfonyldiphenol increases expression ISO Igfbp5 (Mus musculus) 6480464 bisphenol S results in increased expression of IGFBP5 mRNA CTD PMID:30951980 Igfbp5 Rat 4-hydroxyphenyl retinamide decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Fenretinide results in decreased expression of IGFBP5 mRNA CTD PMID:16671099 Igfbp5 Rat 4-hydroxyphenyl retinamide decreases expression ISO Igfbp5 (Mus musculus) 6480464 Fenretinide results in decreased expression of IGFBP5 mRNA CTD PMID:28973697 Igfbp5 Rat 4-nitrophenol decreases expression ISO Igfbp5 (Mus musculus) 6480464 4-nitrophenol results in decreased expression of IGFBP5 mRNA CTD PMID:34673133 Igfbp5 Rat 4-vinylcyclohexene dioxide affects expression ISO Igfbp5 (Mus musculus) 6480464 4-vinyl-1-cyclohexene dioxide affects the expression of IGFBP5 mRNA CTD PMID:20829426 Igfbp5 Rat 5-aza-2'-deoxycytidine multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 Decitabine inhibits the reaction [monomethylarsonous acid results in decreased expression of IGFBP5 mRNA] CTD PMID:16507463 Igfbp5 Rat 5-fluorouracil decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Fluorouracil results in decreased expression of IGFBP5 mRNA CTD PMID:16557594 Igfbp5 Rat 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of IGFBP5 mRNA CTD PMID:24780913 Igfbp5 Rat 8-Br-cAMP increases expression ISO IGFBP5 (Homo sapiens) 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP5 mRNA CTD PMID:20147733|PMID:22079614 Igfbp5 Rat acrylamide decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Acrylamide results in decreased expression of IGFBP5 mRNA CTD PMID:32763439 Igfbp5 Rat aldehydo-D-glucosamine increases expression EXP 6480464 Glucosamine results in increased expression of IGFBP5 mRNA CTD PMID:17109745 Igfbp5 Rat aldehydo-D-glucosamine multiple interactions EXP 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of IGFBP5 mRNA] CTD PMID:17109745 Igfbp5 Rat all-trans-retinoic acid increases expression ISO Igfbp5 (Mus musculus) 6480464 Tretinoin results in increased expression of IGFBP5 mRNA CTD PMID:16604517 Igfbp5 Rat all-trans-retinoic acid decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Tretinoin results in decreased expression of IGFBP5 mRNA CTD PMID:21934132|PMID:23724009 Igfbp5 Rat all-trans-retinoic acid multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [Tretinoin co-treated with Ascorbic Acid] results in decreased expression of IGFBP5 mRNA CTD PMID:16443354 Igfbp5 Rat alpha-Zearalanol multiple interactions EXP 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of IGFBP5 mRNA CTD PMID:35163327 Igfbp5 Rat aluminium trifluoride increases expression ISO IGFBP5 (Homo sapiens) 6480464 aluminum fluoride results in increased expression of IGFBP5 mRNA; aluminum fluoride results in increased expression more ... CTD PMID:11996908 Igfbp5 Rat ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of IGFBP5 mRNA CTD PMID:16483693 Igfbp5 Rat amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of IGFBP5 mRNA CTD PMID:30779732 Igfbp5 Rat amphotericin B decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Amphotericin B results in decreased expression of IGFBP5 mRNA CTD PMID:20849824 Igfbp5 Rat antirheumatic drug increases expression ISO IGFBP5 (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of IGFBP5 mRNA CTD PMID:24449571 Igfbp5 Rat aristolochic acid A decreases expression ISO IGFBP5 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of IGFBP5 mRNA CTD PMID:33212167 Igfbp5 Rat arsane multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:32525701|PMID:39836092 Igfbp5 Rat arsenic atom multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:32525701|PMID:39836092 Igfbp5 Rat arsenite(3-) multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 arsenite inhibits the reaction [Fulvestrant results in increased expression of IGFBP5 mRNA] CTD PMID:31646340 Igfbp5 Rat arsenite(3-) decreases expression ISO IGFBP5 (Homo sapiens) 6480464 arsenite results in decreased expression of IGFBP5 mRNA CTD PMID:31646340 Igfbp5 Rat arsenous acid increases expression ISO IGFBP5 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of IGFBP5 protein CTD PMID:27430728 Igfbp5 Rat arsenous acid multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [Arsenic Trioxide co-treated with Curcumin] results in increased expression of IGFBP5 protein CTD PMID:27430728 Igfbp5 Rat atrazine increases expression ISO IGFBP5 (Homo sapiens) 6480464 Atrazine results in increased expression of IGFBP5 mRNA CTD PMID:22378314 Igfbp5 Rat atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of IGFBP5 mRNA CTD PMID:36841081 Igfbp5 Rat benzamidine decreases degradation EXP 6480464 benzamidine results in decreased degradation of IGFBP5 protein CTD PMID:8894652 Igfbp5 Rat benzo[a]pyrene decreases expression ISO Igfbp5 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of IGFBP5 mRNA CTD PMID:22610609 Igfbp5 Rat benzo[a]pyrene increases methylation ISO IGFBP5 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of IGFBP5 5' UTR; Benzo(a)pyrene results in increased methylation of more ... CTD PMID:27901495 Igfbp5 Rat benzylpenicillin decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Penicillin G results in decreased expression of IGFBP5 mRNA CTD PMID:24737281 Igfbp5 Rat beta-carotene multiple interactions EXP 6480464 [alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium more ... CTD PMID:23859036 Igfbp5 Rat beta-D-glucosamine multiple interactions EXP 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of IGFBP5 mRNA] CTD PMID:17109745 Igfbp5 Rat beta-D-glucosamine increases expression EXP 6480464 Glucosamine results in increased expression of IGFBP5 mRNA CTD PMID:17109745 Igfbp5 Rat bicalutamide increases expression EXP 6480464 bicalutamide results in increased expression of IGFBP5 mRNA CTD PMID:10604720 Igfbp5 Rat bis(2-chloroethyl) sulfide decreases expression ISO Igfbp5 (Mus musculus) 6480464 Mustard Gas results in decreased expression of IGFBP5 mRNA CTD PMID:15674843 Igfbp5 Rat bis(2-ethylhexyl) phthalate multiple interactions ISO Igfbp5 (Mus musculus) 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated more ... CTD PMID:39150890 Igfbp5 Rat bis(2-ethylhexyl) phthalate decreases expression ISO Igfbp5 (Mus musculus) 6480464 Diethylhexyl Phthalate results in decreased expression of IGFBP5 mRNA CTD PMID:33754040 Igfbp5 Rat bisphenol A affects expression ISO IGFBP5 (Homo sapiens) 6480464 bisphenol A affects the expression of IGFBP5 mRNA CTD PMID:21826169 Igfbp5 Rat bisphenol A increases expression ISO Igfbp5 (Mus musculus) 6480464 bisphenol A results in increased expression of IGFBP5 mRNA CTD PMID:30951980|PMID:32156529 Igfbp5 Rat bisphenol A decreases expression ISO IGFBP5 (Homo sapiens) 6480464 bisphenol A results in decreased expression of IGFBP5 mRNA CTD PMID:29275510 Igfbp5 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of IGFBP5 mRNA CTD PMID:25181051|PMID:30816183|PMID:32145629|PMID:34947998|PMID:38750585 Igfbp5 Rat Bisphenol B increases expression ISO IGFBP5 (Homo sapiens) 6480464 bisphenol B results in increased expression of IGFBP5 protein CTD PMID:34186270 Igfbp5 Rat bisphenol F decreases expression ISO IGFBP5 (Homo sapiens) 6480464 bisphenol F results in decreased expression of IGFBP5 mRNA CTD PMID:33476716 Igfbp5 Rat bisphenol F increases expression ISO IGFBP5 (Homo sapiens) 6480464 bisphenol F results in increased expression of IGFBP5 protein CTD PMID:34186270 Igfbp5 Rat bisphenol F increases expression ISO Igfbp5 (Mus musculus) 6480464 bisphenol F results in increased expression of IGFBP5 mRNA CTD PMID:30951980 Igfbp5 Rat Butylbenzyl phthalate multiple interactions ISO Igfbp5 (Mus musculus) 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated more ... CTD PMID:39150890 Igfbp5 Rat Butylbenzyl phthalate increases methylation ISO Igfbp5 (Mus musculus) 6480464 butylbenzyl phthalate results in increased methylation of IGFBP5 intron CTD PMID:28392331 Igfbp5 Rat C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of IGFBP5 mRNA CTD PMID:19167457 Igfbp5 Rat cadmium atom decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Cadmium results in decreased expression of IGFBP5 mRNA CTD PMID:31646340 Igfbp5 Rat cadmium atom multiple interactions ISO Igfbp5 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of IGFBP5 mRNA; more ... CTD PMID:37236586 Igfbp5 Rat cadmium atom multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 Cadmium inhibits the reaction [Fulvestrant results in increased expression of IGFBP5 mRNA] CTD PMID:31646340 Igfbp5 Rat cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of IGFBP5 mRNA CTD PMID:15454312 Igfbp5 Rat cadmium dichloride multiple interactions ISO Igfbp5 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of IGFBP5 mRNA; more ... CTD PMID:37236586 Igfbp5 Rat calcitriol multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 IGFBP5 protein inhibits the reaction [Calcitriol results in increased expression of COL1A1 protein] CTD PMID:17595320 Igfbp5 Rat calcium atom affects expression EXP 6480464 Calcium affects the expression of IGFBP5 mRNA CTD PMID:15913539 Igfbp5 Rat calcium atom decreases degradation EXP 6480464 Calcium results in decreased degradation of IGFBP5 protein CTD PMID:8894652 Igfbp5 Rat calcium(0) decreases degradation EXP 6480464 Calcium results in decreased degradation of IGFBP5 protein CTD PMID:8894652 Igfbp5 Rat calcium(0) affects expression EXP 6480464 Calcium affects the expression of IGFBP5 mRNA CTD PMID:15913539 Igfbp5 Rat carbamazepine affects expression ISO IGFBP5 (Homo sapiens) 6480464 Carbamazepine affects the expression of IGFBP5 mRNA CTD PMID:25979313 Igfbp5 Rat carbon nanotube affects expression ISO Igfbp5 (Mus musculus) 6480464 Nanotubes, Carbon analog affects the expression of IGFBP5 mRNA CTD PMID:25620056 Igfbp5 Rat carbon nanotube decreases expression ISO Igfbp5 (Mus musculus) 6480464 Nanotubes, Carbon analog results in decreased expression of IGFBP5 mRNA; Nanotubes, Carbon results in decreased more ... CTD PMID:25554681 Igfbp5 Rat CGP 52608 multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to IGFBP5 gene] CTD PMID:28238834 Igfbp5 Rat chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of IGFBP5 mRNA CTD PMID:23125180 Igfbp5 Rat chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of IGFBP5 mRNA CTD PMID:18668222 Igfbp5 Rat cisplatin decreases expression ISO Igfbp5 (Mus musculus) 6480464 Cisplatin results in decreased expression of IGFBP5 mRNA CTD PMID:21151649 Igfbp5 Rat cisplatin decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Cisplatin results in decreased expression of IGFBP5 mRNA CTD PMID:20849824 Igfbp5 Rat cisplatin affects response to substance ISO IGFBP5 (Homo sapiens) 6480464 IGFBP5 protein affects the susceptibility to Cisplatin CTD PMID:16217747 Igfbp5 Rat clobetasol decreases expression ISO Igfbp5 (Mus musculus) 6480464 Clobetasol results in decreased expression of IGFBP5 mRNA CTD PMID:27462272 Igfbp5 Rat copper atom increases expression EXP 6480464 Copper results in increased expression of IGFBP5 mRNA CTD PMID:30556269 Igfbp5 Rat copper(0) increases expression EXP 6480464 Copper results in increased expression of IGFBP5 mRNA CTD PMID:30556269 Igfbp5 Rat corticosterone decreases expression EXP 6480464 Corticosterone results in decreased expression of IGFBP5 mRNA CTD PMID:15755911 Igfbp5 Rat cortisol decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Hydrocortisone results in decreased expression of IGFBP5 mRNA CTD PMID:21267416 Igfbp5 Rat coumestrol multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IGFBP5 mRNA; [Coumestrol co-treated with resveratrol] more ... CTD PMID:19167446 Igfbp5 Rat coumestrol decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Coumestrol results in decreased expression of IGFBP5 mRNA CTD PMID:19167446 Igfbp5 Rat crocidolite asbestos decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Asbestos, Crocidolite results in decreased expression of IGFBP5 mRNA CTD PMID:29523930 Igfbp5 Rat Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of IGFBP5 mRNA CTD PMID:26577399 Igfbp5 Rat curcumin multiple interactions ISO Igfbp5 (Mus musculus) 6480464 Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IGFBP5 mRNA] CTD PMID:18200517 Igfbp5 Rat curcumin multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [arsenic trioxide co-treated with Curcumin] results in increased expression of IGFBP5 protein CTD PMID:27430728 Igfbp5 Rat cyclophosphamide decreases expression ISO Igfbp5 (Mus musculus) 6480464 Cyclophosphamide results in decreased expression of IGFBP5 mRNA CTD PMID:15331540 Igfbp5 Rat cyclophosphamide decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Cyclophosphamide results in decreased expression of IGFBP5 mRNA CTD PMID:20849824 Igfbp5 Rat cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of IGFBP5 mRNA CTD PMID:21865292 Igfbp5 Rat cytarabine decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Cytarabine results in decreased expression of IGFBP5 mRNA CTD PMID:21198554 Igfbp5 Rat dexamethasone multiple interactions ISO Igfbp5 (Mus musculus) 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression more ... CTD PMID:16054899 Igfbp5 Rat dexamethasone multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression more ... CTD PMID:28628672 Igfbp5 Rat dexamethasone increases expression ISO IGFBP5 (Homo sapiens) 6480464 Dexamethasone results in increased expression of IGFBP5 mRNA CTD PMID:25047013 Igfbp5 Rat dexamethasone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in decreased expression of IGFBP5 mRNA] CTD PMID:20032058 Igfbp5 Rat dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of IGFBP5 mRNA CTD PMID:20032058 Igfbp5 Rat diarsenic trioxide increases expression ISO IGFBP5 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of IGFBP5 protein CTD PMID:27430728 Igfbp5 Rat diarsenic trioxide multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [Arsenic Trioxide co-treated with Curcumin] results in increased expression of IGFBP5 protein CTD PMID:27430728 Igfbp5 Rat dibenz[a,h]anthracene decreases expression ISO Igfbp5 (Mus musculus) 6480464 1,2,5,6-dibenzanthracene results in decreased expression of IGFBP5 mRNA CTD PMID:26377693 Igfbp5 Rat dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of IGFBP5 mRNA CTD PMID:21266533 Igfbp5 Rat dibutyl phthalate multiple interactions ISO Igfbp5 (Mus musculus) 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated more ... CTD PMID:39150890 Igfbp5 Rat dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of IGFBP5 mRNA CTD PMID:15829613 Igfbp5 Rat diethyl phthalate multiple interactions ISO Igfbp5 (Mus musculus) 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated more ... CTD PMID:39150890 Igfbp5 Rat diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of IGFBP5 mRNA CTD PMID:37077353 Igfbp5 Rat diisobutyl phthalate multiple interactions ISO Igfbp5 (Mus musculus) 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated more ... CTD PMID:39150890 Igfbp5 Rat diisononyl phthalate multiple interactions ISO Igfbp5 (Mus musculus) 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated more ... CTD PMID:39150890 Igfbp5 Rat dimethylarsinous acid decreases expression ISO IGFBP5 (Homo sapiens) 6480464 dimethylarsinous acid results in decreased expression of IGFBP5 mRNA CTD PMID:16507463 Igfbp5 Rat dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression more ... CTD PMID:33729688 Igfbp5 Rat diquat decreases expression ISO Igfbp5 (Mus musculus) 6480464 Diquat results in decreased expression of IGFBP5 mRNA CTD PMID:36851058 Igfbp5 Rat disodium selenite multiple interactions EXP 6480464 [alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium more ... CTD PMID:23859036 Igfbp5 Rat diuron decreases expression EXP 6480464 Diuron results in decreased expression of IGFBP5 mRNA CTD PMID:25152437 Igfbp5 Rat dorsomorphin multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... CTD PMID:27188386 Igfbp5 Rat doxorubicin decreases expression ISO Igfbp5 (Mus musculus) 6480464 Doxorubicin results in decreased expression of IGFBP5 protein CTD PMID:30517846 Igfbp5 Rat doxorubicin increases expression ISO IGFBP5 (Homo sapiens) 6480464 Doxorubicin results in increased expression of IGFBP5 mRNA CTD PMID:29803840 Igfbp5 Rat doxorubicin decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of IGFBP5 mRNA CTD PMID:30031762 Igfbp5 Rat endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of IGFBP5 mRNA CTD PMID:29391264 Igfbp5 Rat Enterolactone multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IGFBP5 mRNA CTD PMID:19167446 Igfbp5 Rat entinostat multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... CTD PMID:27188386 Igfbp5 Rat entinostat decreases expression ISO IGFBP5 (Homo sapiens) 6480464 entinostat results in decreased expression of IGFBP5 mRNA CTD PMID:26272509 Igfbp5 Rat estriol decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Estriol results in decreased expression of IGFBP5 mRNA CTD PMID:15159206 Igfbp5 Rat ethanol multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [Ethanol co-treated with Folic Acid] results in increased expression of IGFBP5 mRNA CTD PMID:23378141 Igfbp5 Rat ethanol increases expression ISO Igfbp5 (Mus musculus) 6480464 Ethanol results in increased expression of IGFBP5 mRNA CTD PMID:30319688 Igfbp5 Rat ethanol affects splicing ISO Igfbp5 (Mus musculus) 6480464 Ethanol affects the splicing of IGFBP5 mRNA CTD PMID:30319688 Igfbp5 Rat ethanol increases expression ISO IGFBP5 (Homo sapiens) 6480464 Ethanol results in increased expression of IGFBP5 mRNA CTD PMID:23378141 Igfbp5 Rat ethylenediaminetetraacetic acid decreases degradation EXP 6480464 Edetic Acid results in decreased degradation of IGFBP5 protein CTD PMID:8894652 Igfbp5 Rat flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of IGFBP5 mRNA CTD PMID:18035473 Igfbp5 Rat fluvastatin multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [zoledronic acid co-treated with fluvastatin] results in increased expression of IGFBP5 mRNA CTD PMID:16996129 Igfbp5 Rat folic acid affects expression ISO IGFBP5 (Homo sapiens) 6480464 Folic Acid affects the expression of IGFBP5 mRNA CTD PMID:17320366 Igfbp5 Rat folic acid multiple interactions ISO Igfbp5 (Mus musculus) 6480464 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of IGFBP5 mRNA CTD PMID:22206623 Igfbp5 Rat folic acid multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [Ethanol co-treated with Folic Acid] results in increased expression of IGFBP5 mRNA CTD PMID:23378141 Igfbp5 Rat formaldehyde increases expression ISO IGFBP5 (Homo sapiens) 6480464 Formaldehyde results in increased expression of IGFBP5 mRNA CTD PMID:28937961 Igfbp5 Rat fulvestrant increases expression ISO IGFBP5 (Homo sapiens) 6480464 Fulvestrant results in increased expression of IGFBP5 mRNA CTD PMID:31646340 Igfbp5 Rat fulvestrant multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 arsenite inhibits the reaction [Fulvestrant results in increased expression of IGFBP5 mRNA]; Cadmium inhibits the more ... CTD PMID:31646340 Igfbp5 Rat genistein decreases expression EXP 6480464 Genistein results in decreased expression of IGFBP5 mRNA CTD PMID:22504913 Igfbp5 Rat gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of IGFBP5 mRNA CTD PMID:22061828|PMID:33387578 Igfbp5 Rat gentamycin decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Gentamicins results in decreased expression of IGFBP5 mRNA CTD PMID:20849824 Igfbp5 Rat hydrazines decreases expression ISO Igfbp5 (Mus musculus) 6480464 Hydrazines results in decreased expression of IGFBP5 mRNA CTD PMID:21647536 Igfbp5 Rat hydrogen peroxide increases expression ISO IGFBP5 (Homo sapiens) 6480464 Hydrogen Peroxide results in increased expression of IGFBP5 mRNA CTD PMID:12414654|PMID:32949572 Igfbp5 Rat Indeno[1,2,3-cd]pyrene decreases expression ISO Igfbp5 (Mus musculus) 6480464 indeno(1,2,3-cd)pyrene results in decreased expression of IGFBP5 mRNA CTD PMID:26377693 Igfbp5 Rat indometacin multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression more ... CTD PMID:28628672 Igfbp5 Rat irinotecan increases expression EXP 6480464 Irinotecan results in increased expression of IGFBP5 mRNA CTD PMID:20097248 Igfbp5 Rat iron dichloride decreases expression ISO IGFBP5 (Homo sapiens) 6480464 ferrous chloride results in decreased expression of IGFBP5 mRNA CTD PMID:35984750 Igfbp5 Rat isoflavones affects expression ISO IGFBP5 (Homo sapiens) 6480464 Isoflavones affects the expression of IGFBP5 mRNA CTD PMID:16365062 Igfbp5 Rat isotretinoin increases expression ISO IGFBP5 (Homo sapiens) 6480464 Isotretinoin results in increased expression of IGFBP5 mRNA CTD PMID:20436886 Igfbp5 Rat ketoconazole increases expression EXP 6480464 Ketoconazole results in increased expression of IGFBP5 mRNA CTD PMID:36653537|PMID:37077353 Igfbp5 Rat L-ascorbic acid multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [Tretinoin co-treated with Ascorbic Acid] results in decreased expression of IGFBP5 mRNA CTD PMID:16443354 Igfbp5 Rat L-ascorbic acid multiple interactions EXP 6480464 [alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium more ... CTD PMID:23859036 Igfbp5 Rat lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of IGFBP5 mRNA CTD PMID:11578147 Igfbp5 Rat linuron decreases expression EXP 6480464 Linuron results in decreased expression of IGFBP5 mRNA CTD PMID:12730624 Igfbp5 Rat lipopolysaccharide multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of IGFBP5 mRNA; [S-(1,2-dichlorovinyl)cysteine more ... CTD PMID:35811015 Igfbp5 Rat manganese atom multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:39836092 Igfbp5 Rat manganese(0) multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:39836092 Igfbp5 Rat manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of IGFBP5 mRNA CTD PMID:28801915 Igfbp5 Rat manganese(II) chloride multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:39836092 Igfbp5 Rat medroxyprogesterone acetate decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Medroxyprogesterone Acetate results in decreased expression of IGFBP5 mRNA CTD PMID:20843944 Igfbp5 Rat menadione increases expression ISO IGFBP5 (Homo sapiens) 6480464 Vitamin K 3 results in increased expression of IGFBP5 mRNA CTD PMID:12414654 Igfbp5 Rat mercury dibromide decreases expression ISO IGFBP5 (Homo sapiens) 6480464 mercuric bromide results in decreased expression of IGFBP5 mRNA CTD PMID:26272509 Igfbp5 Rat metacetamol decreases expression ISO Igfbp5 (Mus musculus) 6480464 3-hydroxyacetanilide results in decreased expression of IGFBP5 mRNA CTD PMID:18544908 Igfbp5 Rat methamphetamine multiple interactions EXP 6480464 IGFBP5 mutant form inhibits the reaction [Methamphetamine results in increased activity of CASP3 protein]; IGFBP5 more ... CTD PMID:25127757 Igfbp5 Rat methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of IGFBP5 mRNA; Methamphetamine results in increased expression of IGFBP5 more ... CTD PMID:25127757 Igfbp5 Rat methotrexate increases expression EXP 6480464 Methotrexate results in increased expression of IGFBP5 mRNA CTD PMID:15120968 Igfbp5 Rat methoxychlor multiple interactions ISO Igfbp5 (Mus musculus) 6480464 [Estradiol co-treated with Methoxychlor metabolite] results in decreased expression of IGFBP5 mRNA CTD PMID:11509743 Igfbp5 Rat methoxychlor decreases expression EXP 6480464 Methoxychlor results in decreased expression of IGFBP5 mRNA CTD PMID:23303685 Igfbp5 Rat methoxychlor decreases expression ISO Igfbp5 (Mus musculus) 6480464 Methoxychlor metabolite results in decreased expression of IGFBP5 mRNA CTD PMID:11509743 Igfbp5 Rat Methylazoxymethanol acetate increases expression EXP 6480464 Methylazoxymethanol Acetate results in increased expression of IGFBP5 mRNA CTD PMID:28349193 Igfbp5 Rat methylmercury chloride decreases expression ISO IGFBP5 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of IGFBP5 mRNA CTD PMID:28001369 Igfbp5 Rat mifepristone decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Mifepristone results in decreased expression of IGFBP5 mRNA CTD PMID:17584828 Igfbp5 Rat Monobutylphthalate increases expression ISO Igfbp5 (Mus musculus) 6480464 monobutyl phthalate results in increased expression of IGFBP5 protein CTD PMID:26903627 Igfbp5 Rat N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of IGFBP5 mRNA CTD PMID:28801915 Igfbp5 Rat N-nitrosodiethylamine increases expression ISO IGFBP5 (Homo sapiens) 6480464 Diethylnitrosamine results in increased expression of IGFBP5 mRNA CTD PMID:21527772 Igfbp5 Rat N-nitrosodiethylamine decreases expression ISO Igfbp5 (Mus musculus) 6480464 Diethylnitrosamine results in decreased expression of IGFBP5 mRNA CTD PMID:24535843 Igfbp5 Rat N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of IGFBP5 mRNA CTD PMID:17032414 Igfbp5 Rat nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of IGFBP5 mRNA; nitrofen results in decreased expression of IGFBP5 more ... CTD PMID:19844724 Igfbp5 Rat Nonylphenol decreases expression ISO IGFBP5 (Homo sapiens) 6480464 nonylphenol results in decreased expression of IGFBP5 mRNA CTD PMID:15159206 Igfbp5 Rat okadaic acid decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Okadaic Acid results in decreased expression of IGFBP5 mRNA CTD PMID:38832940 Igfbp5 Rat oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of IGFBP5 mRNA CTD PMID:25729387 Igfbp5 Rat oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of IGFBP5 mRNA CTD PMID:25729387 Igfbp5 Rat ozone multiple interactions ISO Igfbp5 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of IGFBP5 more ... CTD PMID:34911549 Igfbp5 Rat p-chloromercuribenzoic acid decreases expression ISO IGFBP5 (Homo sapiens) 6480464 p-Chloromercuribenzoic Acid results in decreased expression of IGFBP5 mRNA CTD PMID:26272509 Igfbp5 Rat p-chloromercuribenzoic acid multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Igfbp5 Rat p-menthan-3-ol decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Menthol results in decreased expression of IGFBP5 mRNA CTD PMID:26760959 Igfbp5 Rat paracetamol decreases expression ISO Igfbp5 (Mus musculus) 6480464 Acetaminophen results in decreased expression of IGFBP5 mRNA CTD PMID:18544908 Igfbp5 Rat paraquat increases expression EXP 6480464 Paraquat results in increased expression of IGFBP5 mRNA CTD PMID:18198484 Igfbp5 Rat pentane-2,3-dione decreases expression EXP 6480464 2,3-pentanedione results in decreased expression of IGFBP5 mRNA CTD PMID:25710175 Igfbp5 Rat perfluorooctane-1-sulfonic acid multiple interactions ISO Igfbp5 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of IGFBP5 mRNA CTD PMID:36331819 Igfbp5 Rat perfluorooctanoic acid multiple interactions EXP 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of IGFBP5 mRNA CTD PMID:35163327 Igfbp5 Rat phenformin decreases expression EXP 6480464 Phenformin results in decreased expression of IGFBP5 mRNA CTD PMID:31324951 Igfbp5 Rat phenobarbital affects expression ISO Igfbp5 (Mus musculus) 6480464 Phenobarbital affects the expression of IGFBP5 mRNA CTD PMID:23091169 Igfbp5 Rat phenylephrine decreases expression EXP 6480464 Phenylephrine results in decreased expression of IGFBP5 mRNA CTD PMID:18158353 Igfbp5 Rat phenylmethanesulfonyl fluoride decreases degradation EXP 6480464 Phenylmethylsulfonyl Fluoride results in decreased degradation of IGFBP5 protein CTD PMID:8894652 Igfbp5 Rat phorbol 13-acetate 12-myristate multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of IGFBP5 mRNA CTD PMID:16979875 Igfbp5 Rat pirinixic acid multiple interactions ISO Igfbp5 (Mus musculus) 6480464 PPARA protein promotes the reaction [pirinixic acid results in decreased expression of IGFBP5 mRNA] CTD PMID:20059764 Igfbp5 Rat pirinixic acid decreases expression ISO Igfbp5 (Mus musculus) 6480464 pirinixic acid results in decreased expression of IGFBP5 mRNA CTD PMID:20059764|PMID:23811191 Igfbp5 Rat pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of IGFBP5 mRNA CTD PMID:12832660 Igfbp5 Rat potassium dichromate increases expression ISO Igfbp5 (Mus musculus) 6480464 Potassium Dichromate results in increased expression of IGFBP5 mRNA CTD PMID:23608068 Igfbp5 Rat progesterone multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of IGFBP5 mRNA CTD PMID:20660070 Igfbp5 Rat progesterone decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Progesterone results in decreased expression of IGFBP5 mRNA CTD PMID:18070364|PMID:20864642 Igfbp5 Rat propiconazole decreases expression ISO Igfbp5 (Mus musculus) 6480464 propiconazole results in decreased expression of IGFBP5 mRNA CTD PMID:21278054 Igfbp5 Rat resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of IGFBP5 mRNA CTD PMID:19228061 Igfbp5 Rat resveratrol multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [Coumestrol co-treated with resveratrol] results in decreased expression of IGFBP5 mRNA CTD PMID:19167446 Igfbp5 Rat resveratrol decreases expression ISO IGFBP5 (Homo sapiens) 6480464 resveratrol results in decreased expression of IGFBP5 mRNA CTD PMID:15280659 Igfbp5 Rat rimonabant multiple interactions ISO Igfbp5 (Mus musculus) 6480464 Rimonabant inhibits the reaction [Dietary Fats results in increased expression of IGFBP5 mRNA] CTD PMID:19030233 Igfbp5 Rat rimonabant affects expression ISO Igfbp5 (Mus musculus) 6480464 Rimonabant affects the expression of IGFBP5 mRNA CTD PMID:19030233 Igfbp5 Rat rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of IGFBP5 mRNA CTD PMID:27979718|PMID:28374803 Igfbp5 Rat Rutecarpine decreases expression ISO IGFBP5 (Homo sapiens) 6480464 rutecarpine results in decreased expression of IGFBP5 mRNA CTD PMID:34955744 Igfbp5 Rat S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of IGFBP5 mRNA; [S-(1,2-dichlorovinyl)cysteine more ... CTD PMID:35811015 Igfbp5 Rat S-(1,2-dichlorovinyl)-L-cysteine decreases expression ISO IGFBP5 (Homo sapiens) 6480464 S-(1,2-dichlorovinyl)cysteine results in decreased expression of IGFBP5 mRNA CTD PMID:35811015 Igfbp5 Rat S-nitrosoglutathione increases expression ISO IGFBP5 (Homo sapiens) 6480464 S-Nitrosoglutathione results in increased expression of IGFBP5 mRNA CTD PMID:38825487 Igfbp5 Rat SB 431542 multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... CTD PMID:27188386 Igfbp5 Rat silicon dioxide decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of IGFBP5 mRNA CTD PMID:25895662 Igfbp5 Rat silver atom decreases expression ISO Igfbp5 (Mus musculus) 6480464 Silver results in decreased expression of IGFBP5 mRNA CTD PMID:27131904 Igfbp5 Rat silver(0) decreases expression ISO Igfbp5 (Mus musculus) 6480464 Silver results in decreased expression of IGFBP5 mRNA CTD PMID:27131904 Igfbp5 Rat sirolimus decreases expression EXP 6480464 Sirolimus results in decreased expression of IGFBP5 mRNA CTD PMID:21865292 Igfbp5 Rat sodium arsenate multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of IGFBP5 more ... CTD PMID:32525701 Igfbp5 Rat sodium arsenite decreases expression ISO IGFBP5 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of IGFBP5 mRNA CTD PMID:16507463|PMID:24570342|PMID:25493608|PMID:34032870 Igfbp5 Rat sodium arsenite multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:39836092 Igfbp5 Rat sodium arsenite decreases expression ISO Igfbp5 (Mus musculus) 6480464 sodium arsenite results in decreased expression of IGFBP5 mRNA CTD PMID:17451858 Igfbp5 Rat sodium arsenite increases expression ISO Igfbp5 (Mus musculus) 6480464 sodium arsenite results in increased expression of IGFBP5 mRNA CTD PMID:17077188 Igfbp5 Rat sodium arsenite affects expression ISO Igfbp5 (Mus musculus) 6480464 sodium arsenite affects the expression of IGFBP5 mRNA CTD PMID:16507464 Igfbp5 Rat sodium arsenite increases methylation ISO IGFBP5 (Homo sapiens) 6480464 sodium arsenite results in increased methylation of IGFBP5 gene CTD PMID:24570342 Igfbp5 Rat Soman increases expression EXP 6480464 Soman results in increased expression of IGFBP5 mRNA CTD PMID:19281266 Igfbp5 Rat succimer multiple interactions ISO Igfbp5 (Mus musculus) 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of IGFBP5 mRNA CTD PMID:26378955 Igfbp5 Rat sunitinib decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Sunitinib results in decreased expression of IGFBP5 mRNA CTD PMID:31533062 Igfbp5 Rat tacrolimus hydrate increases expression EXP 6480464 Tacrolimus results in increased expression of IGFBP5 mRNA CTD PMID:21865292 Igfbp5 Rat tamoxifen affects expression ISO IGFBP5 (Homo sapiens) 6480464 Tamoxifen affects the expression of IGFBP5 mRNA CTD PMID:14699072 Igfbp5 Rat tamoxifen increases response to substance ISO IGFBP5 (Homo sapiens) 6480464 IGFBP5 protein results in increased susceptibility to Tamoxifen CTD PMID:20354179 Igfbp5 Rat temozolomide increases expression ISO IGFBP5 (Homo sapiens) 6480464 Temozolomide results in increased expression of IGFBP5 mRNA CTD PMID:31758290 Igfbp5 Rat tert-butyl hydroperoxide increases expression ISO IGFBP5 (Homo sapiens) 6480464 tert-Butylhydroperoxide results in increased expression of IGFBP5 mRNA CTD PMID:12414654 Igfbp5 Rat testosterone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in decreased expression of IGFBP5 mRNA] CTD PMID:20032058 Igfbp5 Rat tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of IGFBP5 mRNA CTD PMID:17032414 Igfbp5 Rat tetraphene decreases expression ISO Igfbp5 (Mus musculus) 6480464 benz(a)anthracene results in decreased expression of IGFBP5 mRNA CTD PMID:26377693 Igfbp5 Rat thapsigargin increases expression ISO IGFBP5 (Homo sapiens) 6480464 Thapsigargin results in increased expression of IGFBP5 mRNA CTD PMID:22378314 Igfbp5 Rat thapsigargin decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Thapsigargin results in decreased expression of IGFBP5 mRNA CTD PMID:29453283 Igfbp5 Rat theophylline decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Theophylline results in decreased expression of IGFBP5 mRNA CTD PMID:16083514 Igfbp5 Rat thimerosal decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Thimerosal results in decreased expression of IGFBP5 mRNA CTD PMID:27188386 Igfbp5 Rat thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of IGFBP5 mRNA CTD PMID:34492290 Igfbp5 Rat Thiorphan affects expression ISO IGFBP5 (Homo sapiens) 6480464 Thiorphan affects the expression of IGFBP5 protein CTD PMID:16405511 Igfbp5 Rat titanium dioxide affects expression ISO Igfbp5 (Mus musculus) 6480464 titanium dioxide affects the expression of IGFBP5 mRNA CTD PMID:23557971 Igfbp5 Rat titanium dioxide decreases methylation ISO Igfbp5 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of IGFBP5 gene CTD PMID:35295148 Igfbp5 Rat topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of IGFBP5 mRNA CTD PMID:25729387 Igfbp5 Rat topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of IGFBP5 mRNA CTD PMID:25729387 Igfbp5 Rat trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of IGFBP5 gene CTD PMID:27618143 Igfbp5 Rat trichostatin A increases expression ISO IGFBP5 (Homo sapiens) 6480464 trichostatin A results in increased expression of IGFBP5 mRNA CTD PMID:24935251 Igfbp5 Rat trichostatin A multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Igfbp5 Rat trichostatin A decreases expression ISO IGFBP5 (Homo sapiens) 6480464 trichostatin A results in decreased expression of IGFBP5 mRNA CTD PMID:26272509 Igfbp5 Rat triclosan increases expression ISO IGFBP5 (Homo sapiens) 6480464 Triclosan results in increased expression of IGFBP5 mRNA CTD PMID:30510588 Igfbp5 Rat trimellitic anhydride decreases expression ISO Igfbp5 (Mus musculus) 6480464 trimellitic anhydride results in decreased expression of IGFBP5 mRNA CTD PMID:19042947 Igfbp5 Rat triptonide decreases expression ISO Igfbp5 (Mus musculus) 6480464 triptonide results in decreased expression of IGFBP5 mRNA CTD PMID:33045310 Igfbp5 Rat troglitazone increases expression ISO IGFBP5 (Homo sapiens) 6480464 troglitazone results in increased expression of IGFBP5 mRNA CTD PMID:19140230 Igfbp5 Rat troglitazone decreases expression ISO Igfbp5 (Mus musculus) 6480464 troglitazone results in decreased expression of IGFBP5 mRNA CTD PMID:28973697 Igfbp5 Rat tunicamycin increases expression ISO IGFBP5 (Homo sapiens) 6480464 Tunicamycin results in increased expression of IGFBP5 mRNA CTD PMID:22378314 Igfbp5 Rat valproic acid decreases methylation ISO IGFBP5 (Homo sapiens) 6480464 Valproic Acid results in decreased methylation of IGFBP5 gene CTD PMID:29154799 Igfbp5 Rat valproic acid decreases expression ISO IGFBP5 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of IGFBP5 mRNA CTD PMID:28001369 Igfbp5 Rat valproic acid affects expression ISO IGFBP5 (Homo sapiens) 6480464 Valproic Acid affects the expression of IGFBP5 mRNA CTD PMID:25979313 Igfbp5 Rat valproic acid increases expression ISO IGFBP5 (Homo sapiens) 6480464 Valproic Acid results in increased expression of IGFBP5 mRNA CTD PMID:24935251 Igfbp5 Rat vanadium atom increases expression ISO IGFBP5 (Homo sapiens) 6480464 Vanadium results in increased expression of IGFBP5 mRNA CTD PMID:19000753 Igfbp5 Rat vanadium(0) increases expression ISO IGFBP5 (Homo sapiens) 6480464 Vanadium results in increased expression of IGFBP5 mRNA CTD PMID:19000753 Igfbp5 Rat vancomycin increases expression ISO Igfbp5 (Mus musculus) 6480464 Vancomycin results in increased expression of IGFBP5 mRNA CTD PMID:18930951 Igfbp5 Rat vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of IGFBP5 mRNA CTD PMID:18042343|PMID:30207508 Igfbp5 Rat vorinostat decreases expression ISO IGFBP5 (Homo sapiens) 6480464 vorinostat results in decreased expression of IGFBP5 mRNA CTD PMID:27188386 Igfbp5 Rat zinc atom multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of IGFBP5 mRNA CTD PMID:16979875 Igfbp5 Rat zinc atom multiple interactions EXP 6480464 [alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium more ... CTD PMID:23859036 Igfbp5 Rat zinc atom decreases expression EXP 6480464 Zinc deficiency results in decreased expression of IGFBP5 mRNA CTD PMID:20128680 Igfbp5 Rat zinc atom decreases degradation EXP 6480464 Zinc results in decreased degradation of IGFBP5 protein CTD PMID:8894652 Igfbp5 Rat zinc(0) multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of IGFBP5 mRNA CTD PMID:16979875 Igfbp5 Rat zinc(0) decreases degradation EXP 6480464 Zinc results in decreased degradation of IGFBP5 protein CTD PMID:8894652 Igfbp5 Rat zinc(0) decreases expression EXP 6480464 Zinc deficiency results in decreased expression of IGFBP5 mRNA CTD PMID:20128680 Igfbp5 Rat zinc(0) multiple interactions EXP 6480464 [alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium more ... CTD PMID:23859036 Igfbp5 Rat zoledronic acid multiple interactions ISO IGFBP5 (Homo sapiens) 6480464 [zoledronic acid co-treated with fluvastatin] results in increased expression of IGFBP5 mRNA CTD PMID:16996129